[oai_citation:0PMC]( Key pointMost findings below come from in vitro or non-human in vivo experiments
Mounjaro is approved only for type 2 diabetes
Coronary artery disease (CAD) led at 40.3% of the deaths attributable to CVD, followed by stroke, other minor CVD causes, high blood pressure, heart failure, and peripheral arterial disease [1]
Whether tumours can co-opt GSH catabolism to fuel their growth is poorly understood
These treatments have drawn a lot of interest because they can lower the risk of serious adverse cardiovascular events like heart attacks and strokes while simultaneously providing glycemic management and cardiovascular protection
Melatonin supports circadian rhythm signaling, sleep initiation, and overnight brain repair processes